← Back to Search

Low Level Laser Therapy

LH80 PRO for Male Pattern Baldness

Phase 2
Waitlist Available
Research Sponsored by Theradome, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 26 weeks
Awards & highlights

Study Summary

This is a prospective, randomized double-blind, multi-center study to evaluate the efficacy of low level laser therapy over-the-counter at home device Theradome LH80 PRO, compared to SHAM for promoting hair growth in males diagnosed with androgenetic alopecia, and a usability study to assess subject ability to self-assess hair loss and understanding use of the device.

Eligible Conditions
  • Male Pattern Baldness

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~26 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 26 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hair growth
Quantitative Hair Growth
Secondary outcome measures
Subject Self Assessment

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: LH80 PROActive Control1 Intervention
Low level laser therapy
Group II: Sham devicePlacebo Group1 Intervention
No low level laser therapy

Find a Location

Who is running the clinical trial?

Theradome, Inc.Lead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~8 spots leftby May 2025